Latest Updates

The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16

The facility had received six observations in Form 483s and was classified as ‘OAI’ (Official Action Indicated’) in March 2019

"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market and commercialise our…

Jubilant is the second largest producer of Vitamin B3 globally

According to the agreement, the joint venture company will now become a subsidiary of Cipla

The clinical trial will evaluate safety and efficacy of two vaccines in a single trial against control group with no vaccine

The facility is now producing high-quality probiotics for the dietary supplement and food and beverage industries

The training, in association with Sharda University, aimed at imparting basic skills to college students on the workflow and…

The company has received a warning letter from the United States Food and Drug Administration (USFDA) as a result of the…

The imported medicines included life-saving drugs, tablets, syrups and vaccines